{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T01:19:47Z","timestamp":1773883187786,"version":"3.50.1"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T00:00:00Z","timestamp":1493164800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s00277-017-3008-8","type":"journal-article","created":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T04:14:53Z","timestamp":1493180093000},"page":"1221-1222","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Successful treatment with bendamustine and rituximab for paraneoplastic pemphigus"],"prefix":"10.1007","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3210-7756","authenticated-orcid":false,"given":"Taku","family":"Kikuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiko","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Koda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryohei","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Kurihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeru","family":"Funakoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Yamagami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidekazu","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyuki","family":"Tsunoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Amagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,26]]},"reference":[{"key":"3008_CR1","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1056\/NEJM199012203232503","volume":"323","author":"GJ Anhalt","year":"1990","unstructured":"Anhalt GJ, Kim SC, Stanley JR, Korman NJ, Jabs DA, Kory M, Izumi H, Ratrie H 3rd, Mutasim D, Ariss-Abdo L, Larib RS (1990) Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 323:1729\u20131735","journal-title":"N Engl J Med"},{"key":"3008_CR2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1440-0960.2012.00921.x","volume":"54","author":"AA Yong","year":"2013","unstructured":"Yong AA, Tey HL (2013) Paraneoplastic pemphigus. Australas J Dermatol 54:241\u2013250","journal-title":"Australas J Dermatol"},{"key":"3008_CR3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000246485","volume":"191","author":"Y Nishibori","year":"1995","unstructured":"Nishibori Y, Hashimoto T, Ishiko A, Shimizu H, Korman NJ, Nishikawa T (1995) Paraneoplastic pemphigus: the first case report from Japan. Dermatology 191:39\u201342","journal-title":"Dermatology"},{"key":"3008_CR4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/sj.thj.6200221","volume":"4","author":"GL Stark","year":"2003","unstructured":"Stark GL, Goff DK, Spickett GP, Wojnarowska F, Langtry JA (2003) Paraneoplastic pemphigus occurring after radiotherapy for relapsed non-Hodgkin\u2019s lymphoma in a patient with common variable immunodeficiency. Hematol J 4:154\u2013158","journal-title":"Hematol J"},{"key":"3008_CR5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/(SICI)1096-8652(199605)52:1<58::AID-AJH10>3.0.CO;2-3","volume":"52","author":"R Plumb","year":"1996","unstructured":"Plumb R, Doolittle GC (1996) Paraneoplastic pemphigus in a patient with non-Hodgkin\u2019s lymphoma. Am J Hematol 52:58\u201359","journal-title":"Am J Hematol"},{"key":"3008_CR6","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/j.1346-8138.2010.01192.x","volume":"38","author":"T Anan","year":"2011","unstructured":"Anan T, Shimizu F, Hatano Y, Okamoto O, Katagiri K, Fujiwara S (2011) Paraneoplastic pemphigus associated with corneal perforation and cutaneous alternariosis: a case report and review of cases treated with rituximab. J Dermatol 38:1084\u20131089","journal-title":"J Dermatol"},{"key":"3008_CR7","doi-asserted-by":"crossref","unstructured":"Rummel M, Kaiser U, Balser C, Stauch M, Brugger W, Welslau M, Niederle N, Losem C, Boeck HP, Weidmann E, von Gruenhagen U, Mueller L, Sandherr M, Hahn L, Vereshchagina J, Kauff F, Blau W, Hinke A, Barth J; Study Group Indolent Lymphomas. Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trial. Lancet Oncol. 2016;17:57\u201366.","DOI":"10.1016\/S1470-2045(15)00447-7"},{"key":"3008_CR8","doi-asserted-by":"crossref","unstructured":"Rummel MJ, Niederle N, Maschmeyer G, Banat GA, von Gr\u00fcnhagen U, Losem C, Kofahl-Krause D, Heil G, Welslau M, Balser C, Kaiser U, Weidmann E, D\u00fcrk H, Ballo H, Stauch M, Roller F, Barth J, Hoelzer D, Hinke A, Brugger W; Study group indolent Lymphomas (StiL). Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial. Lancet 2013;381:1203\u20131210.","DOI":"10.1016\/S0140-6736(12)61763-2"},{"key":"3008_CR9","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00277-014-2202-1","volume":"94","author":"T Higo","year":"2015","unstructured":"Higo T, Miyagaki T, Nakamura F, Shinohara A, Asano H, Abe H, Senda N, Yoshizaki A, Fukayama M, Kurokawa M (2015) Paraneoplastic pemphigus occurring after bendamustine and rituximab therapy for relapsed follicular lymphoma. Ann Hematol 94:683\u2013685","journal-title":"Ann Hematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-017-3008-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-017-3008-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-017-3008-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T20:15:47Z","timestamp":1569096947000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-017-3008-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,26]]},"references-count":9,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["3008"],"URL":"https:\/\/doi.org\/10.1007\/s00277-017-3008-8","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,26]]}}}